MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Movement disorders in children with neurometabolic and neurodegenerative disorders: A single-center prospective study

    A. Saini, S. Khanna, N. Sankhyan (Chandigarh, India)

    Objective: To analyze the prevalence, patterns and severity of movement disorders in children with genetically proven neurometabolic and neurodegenerative diseases. Background: Movement disorders are often…
  • 2023 International Congress

    Use of stimview technology in deep brain stimulation of Parkinson´s disease patients

    A. Rodríguez-Sanz, S. Serrano López, B. Mansilla, M. Román, JF. Paz (Madrid, Spain)

    Objective: We present our experience of Stimview technology in the neurostimulation of 5 patients with Parkinson´s disease (PD). Background: It is common to make adjustments…
  • 2023 International Congress

    Non-intrusive Video-Based Solution for Continuous Quantitative Monitoring of Parkinson’s Patients’ Motor Functions

    A-S. Bridoux, G. Altares, G. Garraux, M. Koivu, L. Mäkitie, E. Fiorenzato, L. Weis, A. Antonini, A. Nieuwboer (Mons, Belgium)

    Objective: Feasibility and preliminary validation of a marker-less solution for automatic capture and quantification of movements during prespecified tasks of people with Parkinson’s (PwP) using…
  • 2023 International Congress

    Custom-made Application Interface using Wacom® Tablet for Assessment of Writer’s Cramp

    K V. Vysakha, VR. Radhakrishnan, PJ. James, SK. Krishnan, DK. K P (Trivandrum, India)

    Objective: To evaluate a custom designed software platform to digitise handwriting data in writers cramp and normal controls. Background: Focal task specific dystonia occurring while…
  • 2023 International Congress

    Evaluation of neuroprotective role of carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model

    D. Khatri, S. Shah, K. Tryphena (Hyderabad, India)

    Objective: To explore the antioxidant and anti-inflammatory role of Carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model Background: NLRP3 inflammasome mediated neuroinflammation is…
  • 2023 International Congress

    The long and short of contemporary parkinsonism survival: A 47-year clinicopathological study

    E. Noyes, AH. Rajput, A. Rajput (Saskatoon, Canada)

    Objective: We report a 47-year survival study of autopsy verified Parkinson syndrome (PS) and Parkinson’s disease (PD) cases. The objectives were: 1) to identify PS…
  • 2023 International Congress

    Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson’s disease: interim analysis of a pilot add-on, randomized, controlled, pragmatic clinical trial

    S. Yuen, KK. Chua, L. Zhong, KW. Chan, C. Chan, CP. Ho, KL. Chan, E. Han, K. Pang, ZX. Lin, V. Mok, N. Cheung, AY. Lau, M. Li (Hong Kong, Hong Kong)

    Objective: This interim data analysis preliminarily evaluated the feasibility and effectiveness of protocolized CHM on motor-related daily living of PD patients. Background: A Chinese national…
  • 2023 International Congress

    KINETIC 2: An ongoing phase 2b, randomized, dose-response study of SAGE-324/BIIB124 for the treatment of essential tremor

    R. Pahwa, A. Ellenbogen, D. Arkilo, T. Dam, T. Lieu, B. Hersh, M. Qin, S. Garafola, M. Gerbasi, H. Colquhoun (Kansas City, KS, USA)

    Objective: KINETIC 2 (NCT05173012) is an ongoing, phase 2b, randomized, double-blind, placebo-controlled, dose-response study that aims to evaluate the efficacy, safety, and tolerability of SAGE-324/BIIB124…
  • 2023 International Congress

    Foslevodopa/foscarbidopa subcutaneous infusion shows similar infusion site reaction severity score across range of infusion rates in patients with Parkinson’s disease

    L. Schlachter, S. Stodtmann, S. Talapala, M. Facheris, M. Rosebraugh (Ludwigshafen, Germany)

    Objective: Characterize the relationship between foslevodopa/foscarbidopa infusion rate and infusion site reaction (ISR) score in patients with Parkinson’s disease (PD) Background: As PD progresses, motor…
  • 2023 International Congress

    Feasibility and efficacy of a multidisciplinary telemedicine intervention program to reduce falls and gait impairment in Parkinson’s disease (NCT04694443).

    A. Garcia-Bustillo, FV. Valiñas Sieiro, A. Olivares, M. Jahouh, J. Gonzalez-Santos, M. Allende, JJ. Gonzalez-Bernal, A. Arnaiz-Gonzalez, J. Diez-Pastor, J. Trejo, JL. Garrido-Labrador, E. Cubo (Burgos, Spain)

    Objective: To evaluate the feasibility and effectiveness of a multidisciplinary telemedicine intervention program to reduce falls and to improve quality of life (QoL) in patients…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley